#vaccines

London, May 30 (PTI) British intelligence agencies now believe it is "feasible" that the COVID-19 pandemic began with a coronavirus leak from a Chinese laboratory, a media report said on Sunday, ...

.New Delhi, Delhi, India
India is currently using made-in-India COVID-19 vaccines, Covishield manufactured by SII and Covaxin of Bharat Biotech. (Photo Credit: PTI)

  • Serum Institute of India (SII) earlier told that its employees had been working continually
  • Earlier, SII told that Covishield production would be ramped up to 6.5 crores in June, seven crores in July

.London, UK
The vaccine is found to be 72% effective in preventing moderate to severe coronavirus infection. (Photo Credit: Twitter/@JNJNews)

  • "This is a further boost to the UK's hugely successful vaccination programme", said the Health Secretary
  • Britain has ordered 20 million doses of the vaccine
  • Britain has administered more than 62 million shots of COVID vaccins so far

.Washington D.C., DC, USA
The United States started a vaccination drive in mid-May for children aged 12-15 against coronavirus.(Photo Credit: Representative Image/Unsplash)

  • The US Centers for Disease Control and Prevention said that there were "relatively few reports of myocarditis"
  • It occurred mostly in teenagers and young adults after they received doses of mRNA
  • Detailed information such as the number of reports or the ages of those affected is not known yet

.Chandigarh, India
American biotechnology company Moderna says its vaccine is 94.1% effective.(Representational/Unsplash)

  • Moderna stated that the company would deal only with the Government of India
  • The state reached out to all such vaccine manufacturers for direct purchases
  • The state, so far, has bought as many as 4.2 lakh COVID vaccine doses of which 3.65 lakh is used up

.New Delhi, Delhi, India
Dr VK Paul serves as Member, NITI Aayog, the government’s public policy think tank. (Photo Credit: ANI)

  • Dr VK Paul said the positivity rate of coronavirus cases was going down in India
  • Government said that children could spread but the mortality is low in them
  • On Tuesday, Dr VK Paul said, "We need to respect our institutions, the world is looking at our systems"

.New Delhi, Delhi, India
WHO scientist says the inequalities in accessing COVID-19 vaccines today hark back to the late 1990s. (Photo Credit: PTI)

  • Effective treatments for HIV were first produced in the mid-1990s
  • The cost of treatment was as high as $10,000 per patient per year 
  • It would take nearly a decade before the poorer populations could avail the treatment for HIV

WHO studies showed that Pfizer and Moderna have shown "reduced effectiveness" against B.1.617 variants of coronavirus.(Photo Credit: Representational Image/ Unsplash)

  • WHO said that the new strains of coronavirus found in India are deadlier and more contagious
  • The B.1.617 variant of the virus was first discovered in India in October 2020
  • it is now detected in 44 countries and has had a higher rate of transmission and higher virulence

Bharat Biotech is an Indian biotechnology company based in Hyderabad. (Photo Credit: Representational Image/Pixabay)

  • Bharat Biotech on Tuesday said that it will proceed with its 'steady supply' of Covaxin to states
  • The states include Bihar, West Bengal, Delhi, Haryana, Uttar Pradesh, Gujarat and others
  • Bharat Biotech earlier cut the price of Covaxin for states to Rs 400 per dose from Rs 600

WHO's appeal comes after Canada's authorisation to administer Pfizer-BioNTech vaccine on children. (Photo credit: AP/PTI)

  • The World Health Organisation on Friday asked global governments to refrain from vaccinating children
  • Canada on Wednesday approved the Pfizer-BioNtech vaccine for children aged 12 years and above
  • Reportedly, the US too is set to authorise the Pfizer vaccine for 12-15 year olds